IP Library › Granted Patent US 11,261,483
Granted Patent B2
US 11,261,483 · App. 15/806,621 · Granted Mar 1, 2022

Programmable DNA-guided artificial restriction enzymes

Inventors: Huimin Zhao (Champaign, IL); Behnam Enghiad (Urbana, IL)
Assignee: BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
C12Q1/683C12N1/20C12N9/22C12N15/66C12Q1/686
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,261,483
App. No.
15/806,621
Granted
Mar 1, 2022
Kind
B2
Abstract

Methods and compositions for specific cleavage of DNA molecules using single-stranded guides and Argonaute (Ago) proteins are described.

Claims (15)

1. A composition comprising:

(a) an isolated Pyrococcus furiosus argonaute (“PfAgo”) protein,

(b) one or more double-stranded linear target DNA molecules,

(c) one or more single-stranded DNA guides that have complementarity to the one or more double-stranded linear target DNA molecules that, when combined with the double-stranded linear target DNA molecules and the isolated PfAgo protein, generate one or more double-stranded linear target DNA molecules having altered 5 or 3′ overhanging ends or blunt ends, and

(d) a plasmid having complementary ends to the one or more double-stranded linear target DNA molecules having altered 5′ or 3° overhanging ends or blunt ends generated by the combination of the one or more single-stranded DNA guides, the double-stranded linear target DNA molecules, and the isolated PfAgo protein,

wherein the PfAgo protein and one or more single-stranded DNA guides do not naturally occur together.

2. The composition of claim 1 , wherein the one or more single-stranded DNA guides are about 9 to about 60 nucleotides in length.

3. The composition of claim 1 , wherein the one or more double-stranded linear target DNA molecules are methylated.

4. The composition of claim 1 , wherein the one or more double-stranded linear target DNA molecules are eukaryotic, prokaryotic, or synthetic DNA molecules.

5. The composition of claim 1 , wherein the one or more DNA guides are synthetic DNA molecules.

6. The composition of claim 1 , wherein the one or more DNA guides are 5′-phosphorylated.

7. The composition of claim 1 , comprising one or more single-stranded DNA guides that have complementarity to one or more double-stranded linear target DNA molecules that, when combined with the double-stranded linear target DNA molecules and the isolated PfAgo protein, generate one or more double-stranded linear target DNA molecules having different lengths or sequences of altered 5′ or 3′ overhanging ends or blunt ends.

8. The composition of claim 1 , wherein the overhanging ends are 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or more nucleotides in length.

9. The composition of claim 1 , wherein the overhanging ends are 2, 3, 4, 5, 6, 7, or 8 nucleotides in length.

10. The composition of claim 1 , wherein the one or more single-stranded DNA guides are 10, 11, 12, 13, 14, 15, 16, 17, or 18 nucleotides in length.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: ZHAO, HUIMIN; ENGHIAD, BEHNAM
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 044372/0037 →
Continuity (2)
Provisional Application 62419692 · Nov 9, 2016
Related Publication 20210087604A1 · Mar 25, 2021